WEST PHARMACEUTICAL SERVICES INC WST
Surgical & Medical Instruments & Apparatus · NYSE
الإيرادات
$2.95B
+2.2% عام على عام
الدخل النقدي
$593.40M
+1.3% عام على عام
الأصول الكلية
$3.64B
-4.9% عام على عام
EPS
7.88
+1.9% عام على عام
Advertisement
بيان الدخل
| الفترة | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Revenues | $2.27B | $1.46B | $698.00M | $2.95B | $2.14B | $1.40B | $695.40M | $2.89B |
| Gross Profit | $800.10M | $505.80M | $231.90M | $1.13B | $724.90M | $460.20M | $230.20M | $1.14B |
| R&D Expense | $52.50M | $35.40M | $16.30M | $68.40M | $50.60M | $35.10M | $17.60M | $58.50M |
| SG&A Expense | $286.60M | $183.90M | $88.00M | $353.40M | $253.20M | $169.70M | $86.70M | $316.90M |
| Operating Income (Loss) | $428.30M | $260.70M | $107.00M | $676.00M | $410.30M | $249.00M | $122.80M | $734.00M |
| Interest Expense | — | — | — | — | — | — | — | — |
| Net Income (Loss) | $89.80M | $89.80M | $89.80M | $593.40M | $115.30M | $115.30M | $115.30M | $585.90M |
| EPS (Diluted) | 4.97 | 3.05 | 1.23 | 7.88 | 4.91 | 3.06 | 1.55 | 7.73 |
بيان الأصول والخصوم
| الفترة | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.27B | $4.27B | $4.27B | $3.64B | $3.64B | $3.64B | $3.64B | $3.83B |
| Current Assets | $1.98B | $1.98B | $1.98B | $1.54B | $1.54B | $1.54B | $1.54B | $1.94B |
| Cash & Equivalents | $791.30M | $791.30M | $791.30M | $484.60M | $484.60M | $484.60M | $484.60M | $853.90M |
| Accounts Receivable | $574.40M | $574.40M | $574.40M | $552.50M | $552.50M | $552.50M | $552.50M | $512.00M |
| Inventory | $443.90M | $443.90M | $443.90M | $377.00M | $377.00M | $377.00M | $377.00M | $434.70M |
| PP&E (Net) | $1.73B | $1.73B | $1.73B | $1.58B | $1.58B | $1.58B | $1.58B | $1.41B |
| Goodwill | $109.90M | $109.90M | $109.90M | $108.50M | $106.00M | $106.00M | $106.00M | $107.30M |
| Total Liabilities | $1.09B | $1.09B | $1.09B | $961.10M | $961.10M | $961.10M | $961.10M | $948.50M |
| Current Liabilities | $654.90M | $654.90M | $654.90M | $550.40M | $550.40M | $550.40M | $550.40M | $671.80M |
| Accounts Payable | $253.70M | $253.70M | $253.70M | $239.30M | $239.30M | $239.30M | $239.30M | $242.40M |
| Long-Term Debt | $202.80M | $202.80M | $202.80M | $202.60M | $202.60M | $202.60M | $202.60M | $206.80M |
| Stockholders Equity | $2.68B | $2.68B | $2.68B | $2.68B | $2.88B | $2.88B | $2.88B | $2.34B |
بيان تدفق النقد
| الفترة | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $503.70M | $306.50M | $129.40M | $776.50M | $463.30M | $283.20M | $118.20M | $724.00M |
| Investing Cash Flow | $-209.80M | $-146.50M | $-71.30M | $-368.70M | $-273.90M | $-191.80M | $-90.60M | $-288.20M |
| Financing Cash Flow | $-173.40M | $-161.90M | $-147.00M | $-459.60M | $-553.70M | $-489.30M | $-271.00M | $-293.60M |
| Stock Repurchases | $134.00M | $134.00M | $133.50M | $438.30M | $506.50M | $454.10M | $267.00M | $202.80M |
شركات مشابهة
BAXTER INTERNATIONAL INC
BAX
BECTON DICKINSON & CO
BDX
BOSTON SCIENTIFIC CORP
BSX
DEXCOM INC
DXCM
3M CO
MMM
INSULET CORP
PODD
RESMED INC
RMD
Solventum Corp
SOLV
تعلم المزيد
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
المعلومات مصدرها قاعدة بيانات SEC EDGAR العامة في الولايات المتحدة. هذا الموقع لا يقدم نصائح استثمارية.